文献速递新发突发、热带与寄生虫病

基于富含组氨酸蛋白-2(First Response)和乳酸脱氢酶(Optimal)的快速诊断试验在儿童镰状细胞病患者疟疾诊断中的性能

Performance of a Histidine Rich Protein-2 Based (First Response) and a p-Lactate Dehydrogenase-based (Optimal) Rapid Diagnostic Test for Diagnosis of Malaria in Patients With Pediatric Sickle Cell Disease.
PubMed 文献 · Clin Infect Dis · 2022-01-01

在加纳阿克拉445例伴急性发热的镰状细胞病患儿中,以常规显微镜检查为参考标准,基于HRP-2的快速诊断试验(First Response)的总体灵敏度、特异度、阳性预测值和阴性预测值分别为100%、95.7%、73.8%和100%;基于LDH的快速诊断试验(Optimal)相应值分别为91.7%、99.5%、95.7%和99.0%。随访时HRP-2试验在多个时间点仍可阳性,而LDH试验阳性率极低。

要点

  • HRP-2快速诊断试验的灵敏度100%、特异度95.7%,符合世界卫生组织疟疾诊断标准。
  • LDH快速诊断试验的灵敏度91.7%、特异度99.5%,阳性预测值95.7%、阴性预测值99.0%。
  • 随访第14、28、35、42天HRP-2阳性率分别为73.7%、52.6%、48.6%、13.2%,LDH分别为0%、2.6%、2.9%、2.6%。

核心结论

  • 基于HRP2的快速诊断试验符合世界卫生组织对镰状细胞病患者疟疾诊断的标准,可为原本仅凭症状经验性治疗的患者提供诊断依据。
  • 基于LDH的快速诊断试验可能更适合作为低寄生虫血症亚组(如镰状细胞病患者)的确认试验。

研究设计与样本

  • 在加纳阿克拉纳入445例伴急性发热的镰状细胞病患儿,比较基于HRP-2的快速诊断试验(First Response)和基于LDH的快速诊断试验(Optimal)与常规显微镜检查(参考标准)的性能。

主要发现

  • HRP-2快速诊断试验的总体灵敏度、特异度、阳性预测值和阴性预测值分别为100%、95.7%、73.8%和100%。
  • LDH快速诊断试验的相应值分别为91.7%、99.5%、95.7%和99.0%。
  • 两种试验均为真阳性的结果共423例,均为假阳性的结果1例,仅HRP-2试验假阳性的结果16例,仅LDH试验假阳性的结果5例(McNemar检验,P=0.03)。
  • 随访第14、28、35、42天,HRP-2试验阳性率分别为73.7%(28/38)、52.6%(20/38)、48.6%(17/35)和13.2%(5/38);LDH试验阳性率分别为0%、2.6%(1/38)、2.9%(1/35)和2.6%(1/38)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rapid diagnostic tests (RDTs) have been extensively evaluated and play an important role in malaria diagnosis. However, the accuracy of RDTs for malaria diagnosis in patients with sickle cell disease (SCD) is unknown. METHODS: We compared the performance of a histidine rich protein 2 (HRP-2)-based RDT (First Response) and a lactate dehydrogenase (LDH)-based RDT (Optimal) with routine microscopy as reference standard in 445 children with SCD and an acute febrile illness in Accra, Ghana. RESULTS: The overall sensitivity, specificity, and positive and negative predictive values of the HRP-2-based RDTs were 100%, 95.7%, 73.8%, and 100%, respectively. Comparable values for the LDH-based RDTs were 91.7%, 99.5%, 95.7%, and 99.0%, respectively. A total of 423 results were true in both tests, 1 result was false in both tests, 16 results were false in the HRP-2 test only, and 5 were false in the LDH test only (McNemar test, P = .03). At follow-up, 73.7% (28/38), 52.6% (20/38), 48.6% (17/35), and 13.2% (5/38) of study participants were HRP-2 positive on days 14, 28, 35, and 42, respectively, compared with 0%, 2.6% (1/38), 2.9% (1/35), and 2.6% (1/38) for LDH. CONCLUSION: The HRP2-based RDT fulfilled World Health Organization criteria for malaria diagnosis in patients with SCD and may provide diagnostic evidence for treatment to begin in cases in which treatment would otherwise have begun presumptively based on symptoms, whereas LDH-based RDTs may be more suitable as a confirmatory test in low-parasitemic subgroups, such as patients with SCD.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Adjei GO, Sulley AM, Goka BQ, et al. Performance of a Histidine Rich Protein-2 Based (First Response) and a p-Lactate Dehydrogenase-based (Optimal) Rapid Diagnostic Test for Diagnosis of Malaria in Patients With Pediatric Sickle Cell Disease. Clin Infect Dis. 2022. PMID: 34849647. doi:10.1093/cid/ciab977

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。